Literature DB >> 15956362

Practical methods using boronic acid compounds for identification of class C beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.

Tetsuya Yagi1, Jun-ichi Wachino, Hiroshi Kurokawa, Satowa Suzuki, Kunikazu Yamane, Yohei Doi, Naohiro Shibata, Haru Kato, Keigo Shibayama, Yoshichika Arakawa.   

Abstract

Detection of the resistance mediated by class C beta-lactamases remains a challenging issue, considering that transferable plasmid-mediated class C beta-lactamases are of worldwide concern. Methods for the identification of strains that produce extended-spectrum beta-lactamases (ESBLs) or metallo-beta-lactamases (MBLs) have been developed and applied for routine use in clinical microbiology laboratories, but no practical methods for identification of plasmid-mediated class C producers have been established to date. We therefore developed three simple methods for clinical microbiology laboratories that allow identification of plasmid-mediated class C beta-lactamase-producing bacteria using a boronic acid derivative, 3-aminophenylboronic acid (APB), one of the specific inhibitors of class C beta-lactamases. Detection by the disk potentiation test was based on the enlargement of the growth-inhibitory zone diameter (by greater than or equal to 5 mm) around a Kirby-Bauer disk containing a ceftazidime (CAZ) or a cefotaxime (CTX) disk in combination with APB. In a double-disk synergy test, the discernible expansion of the growth-inhibitory zone around the CAZ or the CTX disk toward a disk containing APB was indicative of class C beta-lactamase production. A greater than or equal to eightfold decrease in the MIC of CAZ or CTX in the presence of APB was the criterion for detection in the microdilution test. By using these methods, Escherichia coli and Klebsiella pneumoniae isolates producing plasmid-mediated class C beta-lactamases, ACT-1, CMY-2, CMY-9, FOX-5, LAT-1, and MOX-1, were successfully distinguished from those producing other classes of beta-lactamases, such as ESBLs and MBLs. These methods will provide useful information needed for targeted antimicrobial therapy and better infection control.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956362      PMCID: PMC1151917          DOI: 10.1128/JCM.43.6.2551-2558.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  42 in total

Review 1.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Use of beta-lactamase inhibitors in disk tests to detect plasmid-mediated AmpC beta-lactamases.

Authors:  Jennifer A Black; Kenneth S Thomson; Johann D D Pitout
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

Review 3.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

4.  Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center.

Authors:  P E Coudron; E S Moland; K S Thomson
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

5.  Ceftriaxone-resistant salmonella infection acquired by a child from cattle.

Authors:  P D Fey; T J Safranek; M E Rupp; E F Dunne; E Ribot; P C Iwen; P A Bradford; F J Angulo; S H Hinrichs
Journal:  N Engl J Med       Date:  2000-04-27       Impact factor: 91.245

6.  PCR typing of genetic determinants for metallo-beta-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron.

Authors:  Naohiro Shibata; Yohei Doi; Kunikazu Yamane; Tetsuya Yagi; Hiroshi Kurokawa; Keigo Shibayama; Haru Kato; Kumiko Kai; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

7.  Characterization of beta-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom.

Authors:  Ernesto Liebana; Matthew Gibbs; Carol Clouting; Leslie Barker; Felicity A Clifton-Hadley; Eve Pleydell; Baha Abdalhamid; Nancy D Hanson; Laura Martin; Cornelius Poppe; Rob H Davies
Journal:  Microb Drug Resist       Date:  2004       Impact factor: 3.431

8.  Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.

Authors:  Jun-ichi Wachino; Yohei Doi; Kunikazu Yamane; Naohiro Shibata; Tetsuya Yagi; Takako Kubota; Hideo Ito; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

9.  Nanomolar inhibitors of AmpC beta-lactamase.

Authors:  Federica Morandi; Emilia Caselli; Stefania Morandi; Pamela J Focia; Jesús Blázquez; Brian K Shoichet; Fabio Prati
Journal:  J Am Chem Soc       Date:  2003-01-22       Impact factor: 15.419

10.  Kirby-Bauer disc approximation to detect inducible third-generation cephalosporin resistance in Enterobacteriaceae.

Authors:  Xuan Qin; Scott J Weissman; Mary Frances Chesnut; Bei Zhang; Lisong Shen
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-07-15       Impact factor: 3.944

View more
  54 in total

1.  Detection of favorable oral cephalosporin-clavulanate interactions by in vitro disk approximation susceptibility testing of extended-spectrum-Beta-lactamase-producing members of the enterobacteriaceae.

Authors:  Jennifer D Campbell; James S Lewis; M Leticia McElmeel; Letitia C Fulcher; James H Jorgensen
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

Review 2.  Current concepts in laboratory testing to guide antimicrobial therapy.

Authors:  Stephen G Jenkins; Audrey N Schuetz
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

Review 3.  Intestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance Methods.

Authors:  Roberto Viau; Karen M Frank; Michael R Jacobs; Brigid Wilson; Keith Kaye; Curtis J Donskey; Federico Perez; Andrea Endimiani; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

4.  Identification of extended-spectrum, AmpC, and carbapenem- hydrolyzing beta-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests.

Authors:  George A Jacoby; Kelley E Walsh; Victoria J Walker
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

5.  Horizontal transfer of blaCMY-bearing plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY-19.

Authors:  Jun-ichi Wachino; Hiroshi Kurokawa; Satowa Suzuki; Kunikazu Yamane; Naohiro Shibata; Kouji Kimura; Yasuyoshi Ike; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

6.  Performance of the Phoenix bacterial identification system compared with disc diffusion methods for identifying extended-spectrum beta-lactamase, AmpC and KPC producers.

Authors:  Mark A Fisher; Paul D Stamper; Kristine M Hujer; Zachary Love; Ann Croft; Samuel Cohen; Robert A Bonomo; Karen C Carroll; Cathy A Petti
Journal:  J Med Microbiol       Date:  2009-06       Impact factor: 2.472

7.  Large oligoclonal outbreak due to Klebsiella pneumoniae ST14 and ST26 producing the FOX-7 AmpC β-lactamase in a neonatal intensive care unit.

Authors:  Fabio Arena; Tommaso Giani; Elisa Becucci; Viola Conte; Giacomo Zanelli; Marco Maria D'Andrea; Giuseppe Buonocore; Franco Bagnoli; Alessandra Zanchi; Francesca Montagnani; Gian Maria Rossolini
Journal:  J Clin Microbiol       Date:  2013-10-02       Impact factor: 5.948

8.  Impact of derepressed AmpC beta-lactamase ACT-9 on the clinical efficacy of ertapenem.

Authors:  Yi-Tzu Lee; Te-Li Chen; Leung-Kei Siu; Chien-Pei Chen; Chang-Phone Fung
Journal:  Antimicrob Agents Chemother       Date:  2011-06-20       Impact factor: 5.191

9.  Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory.

Authors:  Athanassios Tsakris; Ioulia Kristo; Aggeliki Poulou; Katerina Themeli-Digalaki; Alexandros Ikonomidis; Dimitra Petropoulou; Spyros Pournaras; Danai Sofianou
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

10.  Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coli.

Authors:  Hanna E Sidjabat; David L Paterson; Zubair A Qureshi; Jennifer M Adams-Haduch; Alexandra O'Keefe; Alvaro Pascual; Jesús Rodríguez-Baño; Yohei Doi
Journal:  Clin Infect Dis       Date:  2009-03-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.